Historically, the biopharmaceutical industry has relied on traditional pharmaceutical manufacturing practices to make and release products. This publication examines the future of biopharmaceutical manufacturing by presenting the vision of fully implemented in-line monitoring (ILM) and real-time release. This aspirational vision includes full ILM, predictive analytics and advanced process controls (APC) enabling release of product in real time, with concomitant predictive and preventative alerts and resolution of process, equipment and other production issues.
Phorum
Viewing related articles
Supply chain quality management optimal process and RACI
Jun 2022 | Deliverable, Deliverables Report, Publication, Supply Chain Quality Management, Supply Partner
These tools support sharing the optimal high-level steps to simplify a process and invite people into the discussion using a common language. The optimal process outlines the essential process steps and for each one lists the ‘who’ (i.e., which role) and the ‘how’ (i.e., what medium). The RACI supports people to understand where accountabilities and responsibilities lie.
Accelerating multi-product biopharmaceutical manufacturing facility project lifecycle through modular design
Jun 2022 | Deliverable, Deliverables Report, Publication, Standard Facility Design, Technology Roadmapping
This paper uses a standardized, modular design and construction approach the benefits of a modular design approach to a multi-product viral vector (VV) facility at late-clinical/early-commercial scale, showing how significant speed benefits can be gained at each stage of facility design, procurement, construction, qualification and operation.
BPI Europe May 2022 BSB presentation
May 2022 | Buffer Preparation, Deliverable, Technology Roadmapping, Webinars and podcasts
Forecast and demand planning optimal process tools
May 2022 | Deliverable, Deliverables Report, Forecast and Demand Planning, Forecast and Demand Planning, Publication, Supply Partner
Suite of deliverables to support the forecast and demand planning process and complement the FDP Toolkit. They include an optimal process, RACI and template. These areas are where there is potential for the greatest benefit and will create value for industry when used correctly.
Media and hydrolysates
May 2022 | Cell & Gene Therapy, Deliverable, Drug Substance, Publication, Raw materials, Raw Materials Program, Raw Materials Sourcing
This paper discusses the issues around trace elements and gives a suggested approach for developing a method for analyzing trace elements in cell culture media and hydrolysates. The approach is based on a ground breaking BioPhorum collaboration that shared blinded data and compared analytical methods between biopharmaceutical and media manufacturers.
Member experiences of campaign manufacture with lyophilization processes
May 2022 | Deliverable, Deliverables Report, Fill Finish, Lypholization, Publication
The topic of campaign manufacture for lyophilization processes was discussed by the BioPhorum Lyophilization group. This member only publication is a summary of the approach taken by the major biopharmaceutical companies with experience of campaign manufacture who are members of the group.
Sustainability initiatives
May 2022 | Deliverable, Deliverables Report, Publication, Sustainability
A BioPhorum member only tool providing a useful collection of standards, reporting mechanisms and standards bodies within the sustainability arena
Line clearance risk assessment in secondary packaging areas
May 2022 | Deliverable, Deliverables Report, Fill Finish, Publication
This document describes the basis for performing a risk assessment for line clearance (LC) activities and failures. It contains a general description about the process and a template. This template is meant to support the documentation of the assessment of risks related to the LC process in secondary packaging lines handling pharmaceutical products and combination devices.
Implementation of ready to use cells survey
May 2022 | Benchmarking, Bioassay, Deliverable, Deliverables Report, Development Group
The purpose of this BioPhorum member only survey is to assess the use and control strategy for ready to use (RtU) cells used in bioassays.